Targeting cellular metabolism to improve cancer therapeutics
about
Clinical significance of T cell metabolic reprogramming in cancerFatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancerMetabolomics in rheumatic diseases: desperately seeking biomarkersRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceChemoprevention of Breast Cancer by Dietary PolyphenolsTargeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Cancer Metabolism and Drug ResistanceOvarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionmiR-34: from bench to bedsideSafety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case studyRestoration of mitochondria function as a target for cancer therapyApplication of metabolomics in drug resistant breast cancer researchRedox control of glutamine utilization in cancerHow does the metabolism of tumour cells differ from that of normal cellsCancer cell metabolism: implications for therapeutic targetsTargeting glycogen metabolism in bladder cancer3D microtumors in vitro supported by perfused vascular networks.A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer.Heterogeneity of glycolysis in cancers and therapeutic opportunities.Caveolin-1 in the regulation of cell metabolism: a cancer perspectiveCancer stem cell metabolism: a potential target for cancer therapyAdipose tissue dysfunction and its effects on tumor metabolismType 3 deiodinase: role in cancer growth, stemness, and metabolismMetabolomic profiling of hormone-dependent cancers: a bird's eye viewPreventing Alzheimer's disease by means of natural selectionDetermination of phosphate-activated glutaminase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling PathwayMetabolic control of dendritic cell activation and function: recent advances and clinical implicationsTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsInhibition of lipolysis by mercaptoacetate and etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to paclitaxelApoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activitiesModulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cellsAssessment of the chemosensitizing activity of TAT-RasGAP317-326 in childhood cancersMiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor MetabolismA Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial RespirationAmmonium ions improve the survival of glutamine-starved hybridoma cellsInvestigating Effects of Acidic pH on Proliferation, Invasion and Drug-Induced Apoptosis in Lymphoblastic Leukemia.Effect of Food Additive Citric Acid on The Growth of Human Esophageal Carcinoma Cell Line EC109Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cellsMUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
P2860
Q26741974-A3B5175E-08EA-42EA-BC34-4F9F310A7B55Q26747750-DE097246-13DB-4D94-8EDC-6F092E39B44BQ26765005-2D3CA352-EF86-4726-9CF3-551E58BC9C38Q26765039-CACB5CAC-27DC-4436-9D04-3F59E4873757Q26773449-7E9F478B-9CA0-4CB8-BAEE-8EC45CCFAEE8Q26774957-3DA8A348-07D2-4D1C-A51C-3018000859C5Q26782042-1815ED54-C836-42A7-B5DB-33C2E2770F89Q26786610-426CC173-8FEC-44E8-8304-447C5BA13F40Q26822928-1AE3F017-C1A2-49DE-B821-356AA3A870F1Q26852150-D7306C26-8296-45FA-BFE4-46A282AB8FC8Q26864167-42963252-01FC-4B20-9BFB-D8A2EE9ACD24Q26866291-39EA790E-4F92-4788-90A2-A51890779ED8Q27005615-05F91931-A937-4B17-BD4A-3031FBCE3BA4Q27011856-503DD27E-3C27-4B4F-A2B5-C089930BA006Q27013632-7A24CE35-6B1D-4F92-9066-4F8EDAE58793Q27025144-A9B607B1-E751-46AF-917C-ACCA8DD76169Q27317186-1C6FE660-30C4-44B6-8C3E-242C4DF4A8D0Q27345313-BCA884C8-4F1C-4B01-B3B0-5E02CC41D076Q27693375-B8D2CAD3-67DF-4921-B9F7-F42E90AA8EC8Q28072525-457C2CC7-F6F3-4C20-9F18-579D0D40F363Q28079045-6B3E071A-C5E6-4DB2-A7A0-FA774F3658B4Q28080748-34B55345-DB56-41C9-92EB-BE4401B0B77CQ28080881-7C605240-0A43-44C8-B0DB-4547F7C1B505Q28084834-583A00B6-5B5F-407B-9FFE-3FC268F6D1AFQ28088701-C9285ADE-1B0F-4AD0-ABDE-D4C18522D9B7Q28246788-29AFC12E-ECFF-4557-9D1D-D00469CF8F4BQ28267012-E5B0D326-1927-499A-B053-C883CBF222E2Q28385947-87C135B8-7BC8-41D1-B27A-499B39884CAAQ28391040-64BA7F51-8053-463E-A3FF-F7DD377EEA65Q28533247-00176475-F3C1-4600-8512-81135E4DCD48Q28542724-7263CF3C-CB2D-4837-92A6-C3EA2BF1D687Q28544009-9BB618B6-CE31-4EE0-8B91-567C574EE88FQ28545217-FFF400F9-4F3F-4F3C-B8A2-0C43BFC0538FQ28551765-3993770D-1C3C-4182-A8B4-680A21D6EF70Q28553959-7ADD580E-EE0E-4008-B6C7-46FE45FB0CA0Q28604225-2E2B7F09-9E3C-4B85-9D5F-C4EAA4A174A4Q30363892-1EB5663B-970F-4D5F-9EB9-7948125A00B8Q32183335-DAD8C6F4-FBB2-4F87-AE73-E104CE3B9ADAQ33559623-B8ED9613-32BE-46B7-B44A-D967523F64ACQ33626753-17A37ACC-B686-4095-801B-8EF32FFC2F5E
P2860
Targeting cellular metabolism to improve cancer therapeutics
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting cellular metabolism to improve cancer therapeutics
@ast
Targeting cellular metabolism to improve cancer therapeutics
@en
Targeting cellular metabolism to improve cancer therapeutics
@nl
type
label
Targeting cellular metabolism to improve cancer therapeutics
@ast
Targeting cellular metabolism to improve cancer therapeutics
@en
Targeting cellular metabolism to improve cancer therapeutics
@nl
prefLabel
Targeting cellular metabolism to improve cancer therapeutics
@ast
Targeting cellular metabolism to improve cancer therapeutics
@en
Targeting cellular metabolism to improve cancer therapeutics
@nl
P2860
P3181
P356
P1476
Targeting cellular metabolism to improve cancer therapeutics
@en
P2093
P2860
P3181
P356
10.1038/CDDIS.2013.60
P407
P50
P5008
P577
2013-03-07T00:00:00Z